Giovanni Damiani

Assistant Professor (Ricercatore tipo B)

University of Milan

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Giovanni Damiani is an Assistant Professor (Ricercatore tipo B) at the University of Milan, Italy. His research areas encompass dermatology and dermatological therapies, particularly focusing on innovative treatment strategies for conditions such as psoriasis and hidradenitis suppurativa. He has recently contributed to various studies examining the efficacy of novel therapeutic approaches, including the combined use of lasers and acoustic shock wave therapy, as well as the implications of telemedicine in managing skin disorders.

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (15)

Claudio Guarneri

Assistant Professor of Dermatology and Venereology

University of Messina

ITALY

Giovanni Damiani

Research Interests

Explore related searches

Contact this professor

About

Articles (24)

Evaluation of Combined Treatment With Picosecond Laser and Acoustic Shock Wave Therapy for Tattoo Removal: A Prospective Randomized Controlled Trial

How to Establish the Baseline for Non-Invasive Technological Regenerative Esthetic Medicine in the Face and Neck Region: A Literature Review

Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management

Management of Systemic Anti-psoriatic Drugs in Psoriasis Patients with Concurrent Paraplegia or Tetraplegia: Insights From a 6-Year Multicenter, Retrospective Observational Study

Impaired Molecular Mechanisms Contributing to Chronic Pain in Patients with Hidradenitis Suppurativa: Exploring Potential Biomarkers and Therapeutic Targets

Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS)

Deregulated Long Non-Coding RNAs (lncRNA) as Promising Biomarkers in Hidradenitis Suppurativa

Telemedicine in Nail Psoriasis: Validation of a New Tool to Monitor (In-Person, In-Picture, and In-Video) Nail Psoriasis Severity in Patients with Concurrent Onychophagia and Onychotillomania

Rethinking Hidradenitis Suppurativa Management: Insights into Bacterial Interactions and Treatment Evolution

Structural Basis for p19 Targeting by Anti–IL-23 Biologics: Correlations with Short- and Long-Term Efficacy in Psoriasis

Concurrent Eosinophilia Increases the Prevalence of Nail Abnormalities and Severity of Hair Loss in Patients With Alopecia Areata

Hidradenitis suppurativa associated telomere-methylome dysregulations in blood

Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort

Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study

Antimicrobial Wound Dressings: A Concise Review for Clinicians

The Prevalent Comorbidome at the Onset of Psoriasis Diagnosis

The Relevant Oral Burden of Patients with Hidradenitis Suppurativa

A risankizumab super responder profile identified by long‐term real‐life observation‐IL PSO (ITALIAN LANDSCAPE PSORIASIS)

Circadian Oscillations of Minimal Erythema Dose (MED) are Also Influenced by Diet in Patients with Psoriasis: A Chronomedical Study

Real-World, Retrospective, Multicenter, Observational Study on the Use of the First Liquid AbobotulinumtoxinA in Italy

Heterologous versus homologous primary and booster COVID‐19 vaccination do not increase flare rate in patients with psoriasis and/or psoriatic arthritis: Insights from a real‐life, multicenter, case–control study

Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi Consensus

Cytochrome P450 Genes Mediated by DNA Methylation Are Involved in the Resistance to Hidradenitis Suppurativa

Cutaneous Toll-like Receptor 9 Pre-Defines Hydroxychloroquine Dosage in Patients with Both Discoid and Subacute Lupus Erythematosus

Collaborators (15)

Claudio Guarneri

Giampiero Girolomoni

Gianluigi Ubaldo Mazzoccoli

Angelo Valerio Marzano

MARINA VENTURINI

stefano piaserico

Paolo Gisondi

Lorenzo Peluso

Andrea Carugno

Christopher G. Bunick

Ayman Grada

Anna Balato

Marco Fiore

Francesca Prignano

Mario Valenti

Make your next move.